ESP vs NBIX · P/E 15, rev $9.6M vs P/E 45, rev $2.36B
Espey Mfg & Electronics Corp (ESP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Espey Mfg & Electronics Corp (ESP) is a electrical equipment & parts company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ESP revenue for 2025-06-30 was $9.6M. Net income was $2.9M. Revenue was down 6.9% from 2025-03-31 to 2025-06-30. ESP currently screens at market cap $173.6M and trailing P/E 15.2.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ESP currently screens at market cap $173.6M and trailing P/E 15.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ESP and NBIX stock pages for the full models.
Not investment advice.